ChemAnalyst cites the prices of Etoricoxib in the U.S. market to have seen a sharp fall in the month of April xxxx, as it overturned the trend that was previously observed in the month of March. The fall was mainly due to the lower import cost due to the decrease in the export prices in China and the high inventory levels and weak demand from both the domestic and export market. Weaker global trade dynamics and decrease in rates for freights further buoyed bearish pricing sentiment primarily on the U.S pharmaceutical sector.
-
Etoricoxib prices in U.S. dropped significantly in April xxxx as compared to its increase in March.
-
Etoricoxib import costs dropped considerably because of reduced prices of exportation from China and deteriorating freight rates.
-
Etoricoxib inventories continued to be on high throughout the U.S. supply chain as buyers had front loaded purchases in anticipation of tariff changes.
-
Etoricoxib...
